Brad Spellberg1, Thomas Yoo, Arnold S Bayer. 1. Department of Medicine, Harbor-UCLA Research and Education Institute, 1124 West Carson St., St. John's Cardiovascular Research Center, Torrance, CA 90502, USA. bjs@humc.edu
Abstract
OBJECTIVES: We sought to determine if vitamin B6 therapy would reverse linezolid-associated cytopenias and/or peripheral neuropathy. PATIENTS AND METHODS: We have recently treated two patients with disseminated Mycobacterium abscessus infections with prolonged (> or =9 month) courses of linezolid. Both patients developed cytopenias related to linezolid, and one patient also developed peripheral neuropathy. Because continuing linezolid therapy was required, we administered vitamin B6 (50 mg orally once a day) in an attempt to mitigate the associated cytopenias. RESULTS: The cytopenias in both patients reversed following administration of vitamin B6, and stabilized during prolonged linezolid therapy, although the peripheral neuropathy did not. CONCLUSIONS: Vitamin B6 treatment may be useful to prevent or modify the course of linezolid-associated cytopenias. More formal and rigorous study of vitamin B6 therapy in patients receiving prolonged courses of linezolid is warranted.
OBJECTIVES: We sought to determine if vitamin B6 therapy would reverse linezolid-associated cytopenias and/or peripheral neuropathy. PATIENTS AND METHODS: We have recently treated two patients with disseminated Mycobacterium abscessus infections with prolonged (> or =9 month) courses of linezolid. Both patients developed cytopenias related to linezolid, and one patient also developed peripheral neuropathy. Because continuing linezolid therapy was required, we administered vitamin B6 (50 mg orally once a day) in an attempt to mitigate the associated cytopenias. RESULTS: The cytopenias in both patients reversed following administration of vitamin B6, and stabilized during prolonged linezolid therapy, although the peripheral neuropathy did not. CONCLUSIONS:Vitamin B6 treatment may be useful to prevent or modify the course of linezolid-associated cytopenias. More formal and rigorous study of vitamin B6 therapy in patients receiving prolonged courses of linezolid is warranted.
Authors: Matt Mason; Eric Gregory; Keith Foster; Megan Klatt; Sara Zoubek; Albert J Eid Journal: Open Forum Infect Dis Date: 2022-06-15 Impact factor: 4.423
Authors: Alex Soriano; Mar Ortega; Sebastián García; Georgina Peñarroja; Albert Bové; Miguel Marcos; Juan C Martínez; José A Martínez; Josep Mensa Journal: Antimicrob Agents Chemother Date: 2007-04-30 Impact factor: 5.191
Authors: G Garrabou; À Soriano; T Pinós; J Casanova-Mollà; D Pacheu-Grau; C Morén; E García-Arumí; M Morales; E Ruiz-Pesini; M Catalán-Garcia; J C Milisenda; E Lozano; A L Andreu; J Montoya; J Mensa; F Cardellach Journal: Antimicrob Agents Chemother Date: 2017-08-24 Impact factor: 5.191